Investors and News
Seres Therapeutics is a late-clinical-stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.
lnk Newsread more
Data Provided by Refinitiv. Minimum 15 minutes delayed.